1
Clinical Trials associated with Bevacizumab biosimilar (AskGene Pharma)Pharmacokinetics,Safety and Immunogenicity of ASKB1202 in Chinese Healthy Subjects: a Randomized, Double-blinded, Single-dose, Parallel-arm, Active-comparator Clinical Phase I Study
This trial will investigate the pharmacokinetic,immunogenicity and safety biosimilarity of ASKB1202 compared to bevacizumab sold in China and Europe.
100 Clinical Results associated with Bevacizumab biosimilar (AskGene Pharma)
100 Translational Medicine associated with Bevacizumab biosimilar (AskGene Pharma)
100 Patents (Medical) associated with Bevacizumab biosimilar (AskGene Pharma)
100 Deals associated with Bevacizumab biosimilar (AskGene Pharma)